Zhejiang Huahai Pharmaceutical Co.

Zhejiang Huahai Pharmaceutical Co., Ltd. is principally engaged in the research, development, production and sale of pharmaceutical ingredients, intermediates and preparations. The Company provides metformin hydrochloride sustained-release tablets, irbesartan and hydrochlorothiazide tablets, fosinopril sodium tablets, paroxetine hydrochloride tablets, irbesartan tablets and other products. During the year ended December 31, 2007, the Company obtained approximately 91% of its total revenue from the sale of pharmaceutical ingredients and intermediates. In 2007, approximately 88% of the Company's total revenue was generated from the overseas markets. The Company is headquartered in Linhai, Zhejiang Province, China.